$BMRN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIOMARIN PHARMACEUTICAL INC. Get notifications about new insider transactions in BIOMARIN PHARMACEUTICAL INC for free.
Page: < prev 1 ... 24 25 26 27 28 29 30 31 32 ... 34 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 18 2008 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 33.09 | 1,250 | 41,363 | 62,030 | 63.3 K to 62 K (-1.98 %) |
Mar 18 2008 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 33.08 | 700 | 23,156 | 63,280 | 64 K to 63.3 K (-1.09 %) |
Mar 18 2008 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 33.07 | 200 | 6,614 | 63,980 | 64.2 K to 64 K (-0.31 %) |
Mar 18 2008 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 33.06 | 475 | 15,704 | 64,180 | 64.7 K to 64.2 K (-0.73 %) |
Mar 18 2008 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 33.05 | 668 | 22,077 | 64,655 | 65.3 K to 64.7 K (-1.02 %) |
Mar 18 2008 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 33.04 | 400 | 13,216 | 65,323 | 65.7 K to 65.3 K (-0.61 %) |
Mar 18 2008 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | SVP, Technical Oper ... | Sell | S | 33.03 | 200 | 6,606 | 65,723 | 65.9 K to 65.7 K (-0.30 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.42 | 100 | 3,842 | 30,000 | 30.1 K to 30 K (-0.33 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.41 | 700 | 26,887 | 30,100 | 30.8 K to 30.1 K (-2.27 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.39 | 300 | 11,517 | 30,800 | 31.1 K to 30.8 K (-0.96 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.38 | 100 | 3,838 | 31,100 | 31.2 K to 31.1 K (-0.32 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.34 | 500 | 19,170 | 31,200 | 31.7 K to 31.2 K (-1.58 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.33 | 300 | 11,499 | 31,700 | 32 K to 31.7 K (-0.94 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.32 | 600 | 22,992 | 32,000 | 32.6 K to 32 K (-1.84 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.31 | 138 | 5,287 | 32,600 | 32.7 K to 32.6 K (-0.42 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.30 | 200 | 7,660 | 32,738 | 32.9 K to 32.7 K (-0.61 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.29 | 400 | 15,316 | 32,938 | 33.3 K to 32.9 K (-1.20 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.28 | 300 | 11,484 | 33,338 | 33.6 K to 33.3 K (-0.89 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.27 | 400 | 15,308 | 33,638 | 34 K to 33.6 K (-1.18 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.26 | 200 | 7,652 | 34,038 | 34.2 K to 34 K (-0.58 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.25 | 200 | 7,650 | 34,238 | 34.4 K to 34.2 K (-0.58 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.24 | 1,000 | 38,240 | 34,438 | 35.4 K to 34.4 K (-2.82 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.22 | 300 | 11,466 | 35,438 | 35.7 K to 35.4 K (-0.84 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.21 | 200 | 7,642 | 35,738 | 35.9 K to 35.7 K (-0.56 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.20 | 400 | 15,280 | 35,938 | 36.3 K to 35.9 K (-1.10 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.19 | 100 | 3,819 | 36,338 | 36.4 K to 36.3 K (-0.27 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.17 | 300 | 11,451 | 36,438 | 36.7 K to 36.4 K (-0.82 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.16 | 1,004 | 38,313 | 36,738 | 37.7 K to 36.7 K (-2.66 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.15 | 600 | 22,890 | 37,742 | 38.3 K to 37.7 K (-1.56 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.14 | 900 | 34,326 | 38,342 | 39.2 K to 38.3 K (-2.29 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.13 | 300 | 11,439 | 39,242 | 39.5 K to 39.2 K (-0.76 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.12 | 800 | 30,496 | 39,542 | 40.3 K to 39.5 K (-1.98 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.11 | 600 | 22,866 | 40,342 | 40.9 K to 40.3 K (-1.47 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.10 | 2,100 | 80,010 | 40,942 | 43 K to 40.9 K (-4.88 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.09 | 800 | 30,472 | 43,042 | 43.8 K to 43 K (-1.82 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.08 | 1,200 | 45,696 | 43,842 | 45 K to 43.8 K (-2.66 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.07 | 1,000 | 38,070 | 45,042 | 46 K to 45 K (-2.17 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.06 | 547 | 20,819 | 46,042 | 46.6 K to 46 K (-1.17 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.05 | 700 | 26,635 | 46,589 | 47.3 K to 46.6 K (-1.48 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.04 | 700 | 26,628 | 47,289 | 48 K to 47.3 K (-1.46 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.03 | 700 | 26,621 | 47,989 | 48.7 K to 48 K (-1.44 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.02 | 500 | 19,010 | 48,689 | 49.2 K to 48.7 K (-1.02 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.01 | 300 | 11,403 | 49,189 | 49.5 K to 49.2 K (-0.61 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 38.00 | 200 | 7,600 | 49,489 | 49.7 K to 49.5 K (-0.40 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.96 | 100 | 3,796 | 49,689 | 49.8 K to 49.7 K (-0.20 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.95 | 100 | 3,795 | 49,789 | 49.9 K to 49.8 K (-0.20 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.90 | 100 | 3,790 | 49,889 | 50 K to 49.9 K (-0.20 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.86 | 100 | 3,786 | 49,989 | 50.1 K to 50 K (-0.20 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Option Exercise | M | 5.12 | 30,000 | 153,600 | 75,000 | |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Option Exercise | M | 10.38 | 30,000 | 311,400 | 105,000 | |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.85 | 1,000 | 37,850 | 50,089 | 51.1 K to 50.1 K (-1.96 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.83 | 100 | 3,783 | 51,089 | 51.2 K to 51.1 K (-0.20 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.82 | 100 | 3,782 | 51,189 | 51.3 K to 51.2 K (-0.19 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.80 | 200 | 7,560 | 51,289 | 51.5 K to 51.3 K (-0.39 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.78 | 200 | 7,556 | 51,489 | 51.7 K to 51.5 K (-0.39 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.77 | 100 | 3,777 | 51,689 | 51.8 K to 51.7 K (-0.19 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.76 | 100 | 3,776 | 51,789 | 51.9 K to 51.8 K (-0.19 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.75 | 800 | 30,200 | 51,889 | 52.7 K to 51.9 K (-1.52 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.74 | 700 | 26,418 | 52,689 | 53.4 K to 52.7 K (-1.31 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.73 | 900 | 33,957 | 53,389 | 54.3 K to 53.4 K (-1.66 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.72 | 100 | 3,772 | 54,289 | 54.4 K to 54.3 K (-0.18 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.71 | 100 | 3,771 | 54,389 | 54.5 K to 54.4 K (-0.18 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.70 | 900 | 33,930 | 54,489 | 55.4 K to 54.5 K (-1.62 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.69 | 600 | 22,614 | 55,389 | 56 K to 55.4 K (-1.07 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.68 | 793 | 29,880 | 55,989 | 56.8 K to 56 K (-1.40 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.67 | 200 | 7,534 | 56,782 | 57 K to 56.8 K (-0.35 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.66 | 600 | 22,596 | 56,982 | 57.6 K to 57 K (-1.04 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.65 | 700 | 26,355 | 57,582 | 58.3 K to 57.6 K (-1.20 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.64 | 300 | 11,292 | 58,282 | 58.6 K to 58.3 K (-0.51 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.63 | 100 | 3,763 | 58,582 | 58.7 K to 58.6 K (-0.17 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.62 | 500 | 18,810 | 58,682 | 59.2 K to 58.7 K (-0.84 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.61 | 100 | 3,761 | 59,182 | 59.3 K to 59.2 K (-0.17 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.59 | 218 | 8,195 | 59,282 | 59.5 K to 59.3 K (-0.37 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.55 | 33 | 1,239 | 59,500 | 59.5 K to 59.5 K (-0.06 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.51 | 100 | 3,751 | 59,533 | 59.6 K to 59.5 K (-0.17 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.50 | 200 | 7,500 | 59,633 | 59.8 K to 59.6 K (-0.33 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.49 | 67 | 2,512 | 59,833 | 59.9 K to 59.8 K (-0.11 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Sell | S | 37.47 | 100 | 3,747 | 59,900 | 60 K to 59.9 K (-0.17 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Buy | M | 5.12 | 30,000 | 153,600 | 60,000 | 30 K to 60 K (+100.00 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Buy | M | 10.38 | 30,000 | 311,400 | 30,000 | 0 to 30 K |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Option Exercise | M | 4.00 | 18,000 | 72,000 | 811,502 | |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 38.34 | 100 | 3,834 | 86,164 | 86.3 K to 86.2 K (-0.12 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 38.31 | 200 | 7,662 | 86,264 | 86.5 K to 86.3 K (-0.23 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 38.29 | 200 | 7,658 | 86,464 | 86.7 K to 86.5 K (-0.23 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 38.27 | 1,500 | 57,405 | 86,664 | 88.2 K to 86.7 K (-1.70 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 38.26 | 2,300 | 87,998 | 88,164 | 90.5 K to 88.2 K (-2.54 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 38.25 | 3,000 | 114,750 | 90,464 | 93.5 K to 90.5 K (-3.21 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 38.24 | 700 | 26,768 | 93,464 | 94.2 K to 93.5 K (-0.74 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 38.23 | 500 | 19,115 | 94,164 | 94.7 K to 94.2 K (-0.53 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 38.22 | 200 | 7,644 | 94,664 | 94.9 K to 94.7 K (-0.21 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 38.21 | 300 | 11,463 | 94,864 | 95.2 K to 94.9 K (-0.32 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 38.20 | 200 | 7,640 | 95,164 | 95.4 K to 95.2 K (-0.21 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 38.16 | 200 | 7,632 | 95,364 | 95.6 K to 95.4 K (-0.21 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 38.15 | 300 | 11,445 | 95,564 | 95.9 K to 95.6 K (-0.31 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 38.14 | 400 | 15,256 | 95,864 | 96.3 K to 95.9 K (-0.42 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 38.13 | 800 | 30,504 | 96,264 | 97.1 K to 96.3 K (-0.82 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 38.12 | 200 | 7,624 | 97,064 | 97.3 K to 97.1 K (-0.21 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 38.11 | 400 | 15,244 | 97,264 | 97.7 K to 97.3 K (-0.41 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 38.10 | 300 | 11,430 | 97,664 | 98 K to 97.7 K (-0.31 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 38.08 | 200 | 7,616 | 97,964 | 98.2 K to 98 K (-0.20 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 38.07 | 400 | 15,228 | 98,164 | 98.6 K to 98.2 K (-0.41 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 38.06 | 500 | 19,030 | 98,564 | 99.1 K to 98.6 K (-0.50 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 38.05 | 500 | 19,025 | 99,064 | 99.6 K to 99.1 K (-0.50 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 38.04 | 1,200 | 45,648 | 99,564 | 100.8 K to 99.6 K (-1.19 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 38.03 | 500 | 19,015 | 100,764 | 101.3 K to 100.8 K (-0.49 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 38.02 | 1,200 | 45,624 | 101,264 | 102.5 K to 101.3 K (-1.17 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 38.01 | 1,300 | 49,413 | 102,464 | 103.8 K to 102.5 K (-1.25 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 38.00 | 300 | 11,400 | 103,764 | 104.1 K to 103.8 K (-0.29 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Sell | S | 37.99 | 100 | 3,799 | 104,064 | 104.2 K to 104.1 K (-0.10 %) |
Mar 10 2008 | BMRN | BIOMARIN PHARMACEU ... | KAKKIS EMIL D | Chief Medical Offic ... | Buy | M | 4.00 | 18,000 | 72,000 | 104,164 | 86.2 K to 104.2 K (+20.89 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.45 | 200 | 7,690 | 5,000 | 5.2 K to 5 K (-3.85 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.44 | 200 | 7,688 | 5,200 | 5.4 K to 5.2 K (-3.70 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.43 | 100 | 3,843 | 5,400 | 5.5 K to 5.4 K (-1.82 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.42 | 600 | 23,052 | 5,500 | 6.1 K to 5.5 K (-9.84 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.41 | 1,400 | 53,774 | 6,100 | 7.5 K to 6.1 K (-18.67 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.40 | 900 | 34,560 | 7,500 | 8.4 K to 7.5 K (-10.71 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.39 | 100 | 3,839 | 8,400 | 8.5 K to 8.4 K (-1.18 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Option Exercise | M | 10.33 | 30,000 | 309,900 | 37,500 | |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.36 | 100 | 3,836 | 8,500 | 8.6 K to 8.5 K (-1.16 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.35 | 500 | 19,175 | 8,600 | 9.1 K to 8.6 K (-5.49 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.34 | 500 | 19,170 | 9,100 | 9.6 K to 9.1 K (-5.21 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.33 | 700 | 26,831 | 9,600 | 10.3 K to 9.6 K (-6.80 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.31 | 1,000 | 38,310 | 10,300 | 11.3 K to 10.3 K (-8.85 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.30 | 300 | 11,490 | 11,300 | 11.6 K to 11.3 K (-2.59 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.27 | 500 | 19,135 | 11,600 | 12.1 K to 11.6 K (-4.13 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.26 | 200 | 7,652 | 12,100 | 12.3 K to 12.1 K (-1.63 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.25 | 903 | 34,540 | 12,300 | 13.2 K to 12.3 K (-6.84 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.24 | 600 | 22,944 | 13,203 | 13.8 K to 13.2 K (-4.35 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.23 | 1,100 | 42,053 | 13,803 | 14.9 K to 13.8 K (-7.38 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.22 | 600 | 22,932 | 14,903 | 15.5 K to 14.9 K (-3.87 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.21 | 900 | 34,389 | 15,503 | 16.4 K to 15.5 K (-5.49 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.20 | 900 | 34,380 | 16,403 | 17.3 K to 16.4 K (-5.20 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.19 | 300 | 11,457 | 17,303 | 17.6 K to 17.3 K (-1.70 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.18 | 443 | 16,914 | 17,603 | 18 K to 17.6 K (-2.45 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.17 | 950 | 36,262 | 18,046 | 19 K to 18 K (-5.00 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.16 | 1,700 | 64,872 | 18,996 | 20.7 K to 19 K (-8.21 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.15 | 100 | 3,815 | 20,696 | 20.8 K to 20.7 K (-0.48 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.14 | 1,100 | 41,954 | 20,796 | 21.9 K to 20.8 K (-5.02 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.13 | 204 | 7,779 | 21,896 | 22.1 K to 21.9 K (-0.92 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.11 | 1,900 | 72,409 | 22,100 | 24 K to 22.1 K (-7.92 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.10 | 1,200 | 45,720 | 24,000 | 25.2 K to 24 K (-4.76 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.08 | 100 | 3,808 | 25,200 | 25.3 K to 25.2 K (-0.40 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.07 | 1,600 | 60,912 | 25,300 | 26.9 K to 25.3 K (-5.95 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.06 | 1,000 | 38,060 | 26,900 | 27.9 K to 26.9 K (-3.58 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.05 | 800 | 30,440 | 27,900 | 28.7 K to 27.9 K (-2.79 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.04 | 500 | 19,020 | 28,700 | 29.2 K to 28.7 K (-1.71 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Sell | S | 38.03 | 800 | 30,424 | 29,200 | 30 K to 29.2 K (-2.67 %) |
Mar 07 2008 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Buy | M | 10.33 | 30,000 | 309,900 | 30,000 | 0 to 30 K |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | VP, General Counsel | Option Exercise | M | 6.13 | 4,000 | 24,520 | 206,000 | |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | VP, General Counsel | Option Exercise | M | 7.84 | 16,000 | 125,440 | 210,000 |